What is the ICD‑10‑CM diagnosis code for trisomies other than trisomy 21?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-10-CM Diagnosis Codes for Trisomies Other Than Trisomy 21

For trisomies other than trisomy 21 (Down syndrome), use ICD-10-CM code Q91.4-Q91.7 for trisomy 13 (Patau syndrome) and Q91.0-Q91.3 for trisomy 18 (Edwards syndrome).

Specific Code Structure

The ICD-10-CM coding system organizes autosomal trisomies under the Q91 category, with distinct subcategories based on the specific trisomy and its genetic mechanism:

Trisomy 18 (Edwards Syndrome)

  • Q91.0 - Trisomy 18, nonmosaicism (meiotic nondisjunction)
  • Q91.1 - Trisomy 18, mosaicism (mitotic nondisjunction)
  • Q91.2 - Trisomy 18, translocation
  • Q91.3 - Trisomy 18, unspecified

Trisomy 13 (Patau Syndrome)

  • Q91.4 - Trisomy 13, nonmosaicism (meiotic nondisjunction)
  • Q91.5 - Trisomy 13, mosaicism (mitotic nondisjunction)
  • Q91.6 - Trisomy 13, translocation
  • Q91.7 - Trisomy 13, unspecified

Clinical Context

Both trisomy 13 and trisomy 18 are significantly less common than trisomy 21, occurring in approximately 1:6,000-8,000 live births for trisomy 18 and 1:10,000-20,000 for trisomy 13 1. These conditions are associated with multiple congenital anomalies and historically high infant mortality, though recent clinical approaches have evolved toward individualized care planning 2.

Key Diagnostic Considerations

Prenatal screening can detect approximately 70-95% of trisomy 13 and 18 cases through maternal serum screening (triple or quad screen) or cell-free DNA testing 1, 3, 4. When isolated soft markers are identified on ultrasound (particularly choroid plexus cysts for trisomy 18), genetic counseling and screening options should be discussed 5.

Confirmatory testing requires chromosome analysis via amniocentesis or chorionic villus sampling (CVS), as screening tests alone cannot definitively diagnose these conditions 6. The positive predictive value varies significantly based on maternal age and the specific screening method used 7.

Important Coding Distinctions

The fourth character in these codes is clinically significant because it specifies the genetic mechanism:

  • Nonmosaicism (full trisomy) represents the most common form, occurring in approximately 95% of cases
  • Mosaicism indicates the presence of both normal and trisomic cell lines, typically associated with milder phenotypes
  • Translocation forms are less common but important for recurrence risk counseling

When the specific genetic mechanism is unknown at the time of coding, use the "unspecified" codes (Q91.3 for trisomy 18, Q91.7 for trisomy 13).

Common Pitfall

Do not use Q90.x codes (which are specific to trisomy 21/Down syndrome) for other trisomies. The Q91 category is specifically designated for trisomy 18, trisomy 13, and other autosomal trisomies excluding trisomy 21.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.